MedTrace Logo

MTA and Biodentine in Pulpotomized Primary Molars

NCT01591278 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2014-11-13

No results posted yet for this study

Summary

The objective of the study is to evaluate and compare, clinically and radiographically,the effects of MTA and Biodentine when used as pulp dressings following pulpotomy in human primary molars.

Conditions

  • Primary Molar Pulpotomy

Interventions

OTHER

Pulpotomy

Comparison of two different pulp dressing agents

OTHER

Pulpotomy

Comparison of two different pulp dressing agents

Sponsors & Collaborators

  • Cristina Cuadros

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
4 Years
Max Age
9 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-03-31
Primary Completion
2014-02-28
Completion
2014-11-30

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01591278 on ClinicalTrials.gov